RankingsPricing
  1. US-listed companies
  2. Zivo Bioscience, Inc.

Zivo Bioscience, Inc.ZIVO

Market cap
$25.47M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Service Revenue---------20,000--
Total Revenues103,891--------20,000--
General and administrative603,104938,1981,189,812907,156963,296832,2392,127,9791,353,3194,076,4391,948,42376
Research and development377,893677,4901,018,0231,971,1751,033,351788,9712,381,2222,814,9912,307,0333,754,91322
Total Costs and Expenses2,042,1992,080,5933,110,1975,153,1373,056,2803,490,4446,330,1866,130,6438,352,3508,575,67599
LOSS FROM OPERATIONS-1,938,308-2,080,593-3,110,197-5,153,137-3,056,280-3,490,444-6,330,186-6,130,643-8,352,350-8,555,675-9,052,605-8,731,974
Gain of forgiveness of debt and accrued interest-------406,482---122,520-
Interest expense - related parties----------188,604-
Interest expense-47,113-141,734-441,477-589,573720,711-35,490----44,67713,319
Total Other Expense-793,303-1,167,812----2,569,183-3,708,188-8,504,724-3,157,816-550,054-110,761-13,319
NET LOSS-2,731,610-3,248,405-10,095,878680,811-5,789,131-6,059,627-10,038,374-14,635,367-11,510,166-9,105,729-9,163,366-8,745,293
BASIC AND DILUTED LOSS PER SHARE------------0.93